HIGHLIGHTS
- who: Heinrich Worth from the Clinical Research, Respiratory, Novartis Pharma GmbH, Nu00fcrnberg, Germany , Department of Medicine, Pulmonary and Critical Care Medicine, German Center for Lung Research (DZL), University Medical Centre Giessen and Marburg, Philipps-University Marburg, Marburg, Germany have published the article: In u2018real worldu2019 patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations, in the Journal: (JOURNAL)
- how: The prespecified analyses did not take exacerbation history into account and the authors therefore decided to perform additional post-hoc analyses of these data combining eosinophil counts with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.